Vasundhara Rasayans Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 552857,
    "name": "Vasundhara Rasy.",
    "stock_name": "Vasundhara Rasy.",
    "full_name": "Vasundhara Rasayans Ltd",
    "name_url": "stocks-analysis/vasundhara-rasy",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "178.00",
    "chg": 6.9,
    "chgp": "4.03%",
    "dir": 1,
    "prev_price": "171.10",
    "mcapval": "57.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 538634,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 11,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE406F01010",
    "curr_date": "Jun 24, 12:40 PM",
    "curr_time": "12:42 PM",
    "last_traded_at": "Jun 24, 12:40 PM IST",
    "bse_nse_vol": "3.4 k",
    "exc_status": "Active",
    "traded_date": "Jun 24, 2026",
    "traded_date_str": "2026 06 24",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vasundhara-rasy-552857-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Vasundhara Rasayans Ltd Valuation Shifts Signal Price Attractiveness Change",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vasundhara-rasayans-ltd-valuation-shifts-signal-price-attractiveness-change-4069474",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/VasundharaRasay_valuationdot_4069474.png",
        "date": "2026-06-24 08:00:33",
        "description": "Vasundhara Rasayans Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. This change reflects evolving market perceptions and impacts the stock’s price attractiveness amid a challenging sector backdrop and mixed financial metrics."
      },
      {
        "title": "Vasundhara Rasayans Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vasundhara-rasayans-ltd-is-rated-strong-sell-4061081",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/VasundharaRasay_mojoScore_4061081.png",
        "date": "2026-06-18 10:10:34",
        "description": "Vasundhara Rasayans Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Dec 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 18 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Vasundhara Rasayans Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vasundhara-rasayans-ltd-valuation-shifts-signal-renewed-price-attractiveness-4045716",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/VasundharaRasay_valuationdot_4045716.png",
        "date": "2026-06-11 08:00:38",
        "description": "Vasundhara Rasayans Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from a very expensive rating to a fair valuation grade. This change, coupled with its current price-to-earnings (P/E) ratio of 13.14 and price-to-book value (P/BV) of 1.40, suggests a more attractive entry point for investors compared to its historical and peer averages."
      },
      {
        "title": "Vasundhara Rasayans Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vasundhara-rasayans-ltd-is-rated-strong-sell-4035933",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/VasundharaRasay_mojoScore_4035933.png",
        "date": "2026-06-04 10:10:20",
        "description": "Vasundhara Rasayans Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 June 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Vasundhara Rasayans Ltd Valuation Shifts Amid Mixed Market Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vasundhara-rasayans-ltd-valuation-shifts-amid-mixed-market-performance-4025223",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/VasundharaRasay_valuationdot_4025223.png",
        "date": "2026-06-01 08:03:09",
        "description": "Vasundhara Rasayans Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from an attractive to a fair rating. Despite a robust intraday price surge of 19.98% to ₹148.90 on 1 June 2026, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now reflect a more tempered market sentiment compared to its historical averages and peer benchmarks."
      },
      {
        "title": "When is the next results date for Vasundhara Rasayans Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-vasundhara-rasayans-ltd-4003779",
        "imagepath": "",
        "date": "2026-05-21 23:17:49",
        "description": "The next results date for Vasundhara Rasayans Ltd is scheduled for 28 May 2026...."
      },
      {
        "title": "Vasundhara Rasayans Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vasundhara-rasayans-ltd-is-rated-strong-sell-4002752",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/VasundharaRasay_mojoScore_4002752.png",
        "date": "2026-05-21 10:10:42",
        "description": "Vasundhara Rasayans Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Dec 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 21 May 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Vasundhara Rasayans Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vasundhara-rasayans-ltd-valuation-shifts-signal-renewed-price-attractiveness-amid-market-challenges-3995940",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/VasundharaRasay_valuationdot_3995940.png",
        "date": "2026-05-18 08:01:20",
        "description": "Vasundhara Rasayans Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, despite ongoing sector headwinds and a challenging price performance relative to the Sensex. This repositioning is underpinned by a significant contraction in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios, suggesting a potential entry point for value-focused investors within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Vasundhara Rasayans Ltd Valuation Shifts Signal Changing Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vasundhara-rasayans-ltd-valuation-shifts-signal-changing-market-sentiment-3984567",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/VasundharaRasay_valuationdot_3984567.png",
        "date": "2026-05-11 08:01:07",
        "description": "Vasundhara Rasayans Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift from attractive to fair, reflecting a nuanced change in investor sentiment. Despite a modest day gain of 0.27%, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now align more closely with sector averages, signalling a recalibration of its price attractiveness amid challenging market returns."
      }
    ],
    "total": 263,
    "sid": "552857",
    "stock_news_url": "https://www.marketsmojo.com/news/vasundhara-rasayans-552857"
  },
  "announcements": [
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "30-May-2026",
      "details": "ANNUAL SECRETARIAL COMPLIANCE REPORT FOR THE FY 2025-26",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "30-May-2026",
      "details": "Newspaper Advertisement pertaining Audited financial results for the quarter and year ended on 31.03.2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements",
      "datetime": "28-May-2026",
      "details": "The Board of Directors in its meeting held on 28th May 2026 has approved and taken on records the entering into of a Memorandum of Understanding cum Loan-lease agreement with PandJ Cretechem Private Limited (the Holding Company) for a manufacturing arrangement for Active Pharmaceutical Ingredients (APIs) at the Holding companys manufacturing facility located at Dahej Gujarat",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Vasundhara Rasayans Ltd has declared <strong>20%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Vasundhara Rasayans Ltd Valuation Shifts Signal Price Attractiveness Change

2026-06-24 08:00:33

Vasundhara Rasayans Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. This change reflects evolving market perceptions and impacts the stock’s price attractiveness amid a challenging sector backdrop and mixed financial metrics.

Read full news article

Vasundhara Rasayans Ltd is Rated Strong Sell

2026-06-18 10:10:34

Vasundhara Rasayans Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Dec 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 18 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Vasundhara Rasayans Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-06-11 08:00:38

Vasundhara Rasayans Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from a very expensive rating to a fair valuation grade. This change, coupled with its current price-to-earnings (P/E) ratio of 13.14 and price-to-book value (P/BV) of 1.40, suggests a more attractive entry point for investors compared to its historical and peer averages.

Read full news article

Vasundhara Rasayans Ltd is Rated Strong Sell

2026-06-04 10:10:20

Vasundhara Rasayans Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 June 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Vasundhara Rasayans Ltd Valuation Shifts Amid Mixed Market Performance

2026-06-01 08:03:09

Vasundhara Rasayans Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from an attractive to a fair rating. Despite a robust intraday price surge of 19.98% to ₹148.90 on 1 June 2026, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now reflect a more tempered market sentiment compared to its historical averages and peer benchmarks.

Read full news article

When is the next results date for Vasundhara Rasayans Ltd?

2026-05-21 23:17:49

The next results date for Vasundhara Rasayans Ltd is scheduled for 28 May 2026....

Read full news article

Vasundhara Rasayans Ltd is Rated Strong Sell

2026-05-21 10:10:42

Vasundhara Rasayans Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 Dec 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 21 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Vasundhara Rasayans Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Market Challenges

2026-05-18 08:01:20

Vasundhara Rasayans Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, despite ongoing sector headwinds and a challenging price performance relative to the Sensex. This repositioning is underpinned by a significant contraction in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios, suggesting a potential entry point for value-focused investors within the Pharmaceuticals & Biotechnology sector.

Read full news article

Vasundhara Rasayans Ltd Valuation Shifts Signal Changing Market Sentiment

2026-05-11 08:01:07

Vasundhara Rasayans Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift from attractive to fair, reflecting a nuanced change in investor sentiment. Despite a modest day gain of 0.27%, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now align more closely with sector averages, signalling a recalibration of its price attractiveness amid challenging market returns.

Read full news article

View All News